性感染症（STD）検査の世界市場レポート2025年

性感染症（STD）検査の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.3％で、120億8,000万米ドルに成長します。このような成長が見込まれる背景には、世界の性病罹患率の上昇、性の健康問題に対する意識の高まり、自覚症状のない感染率の高さ、性的に活発な青年や若年成人の増加、リスクの高い性行動の急増などがあります。予測される主な動向には、迅速検査やポイントオブケア検査の台頭、家庭用STD検査キットの出現、分子診断法の進歩、診断ラボにおける自動化とAI統合の進展、新しい検査キットの精度と信頼性の向上などがあります。

HIVの有病率の増加は、今後数年間の性感染症（STD）検査市場の成長を促進すると予想されます。HIVは重要な白血球を攻撃して破壊するため、免疫系が弱まり、感染症や病気にかかりやすくなります。HIV感染者の増加は、無防備なセックスのような危険な行動をとる人の増加や、検査を受ける人の減少、特に若者の減少につながっています。このようなHIV感染者の増加により、一般の人々や医療関係者の意識が高まり、感染を早期に発見し、さらなる感染拡大を防ぐために総合的な検査を受ける人が増えています。例えば、2024年7月の国連合同エイズ計画（UNAIDS）によると、2023年に新たにHIVに感染した人は約130万人で、37万人未満という2025年の目標値の約3倍となっています。したがって、HIVの有病率の増加は、STD検査の需要を高めると予想されます。

性感染症（STD）検査市場の主な企業は、アクセシビリティと精度を向上させるため、梅毒検査キットなどの先進ソリューションの開発に注力しています。これらのキットは、血液やその他の体液を用いて梅毒の原因菌であるトレポネーマ・パリダム菌を検出し、タイムリーな診断と治療を可能にします。例えば、2023年8月、米国の医療機器会社であるiHealth Labs Inc.は、HIVと梅毒検査用のCheckMeSafeホームコレクションキットを発売しました。このFDA認可のキットは、18歳以上の個人がHIV（i、ii、P24抗原）と梅毒検査のために自宅で血液サンプルを採取することを可能にします。ユーザーは、前払いのオーバーナイトラベルでサンプルをラボに送り、最短2日で機密性の高い信頼できる結果を受け取ることができます。キットの感度はHIVで99.9%、梅毒で99.5%に達し、高い精度を提供します。すべてのサンプルはCLIA認定およびCAP認定の検査機関で検査され、定期的な検査により、連邦および州の厳格な品質基準への準拠が保証されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の性感染症（STD）検査：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の性感染症（STD）検査市場：成長率分析
• 世界の性感染症（STD）検査市場の実績：規模と成長, 2019-2024
• 世界の性感染症（STD）検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界の性感染症（STD）検査：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の性感染症（STD）検査市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器とサービス
• 消耗品
• ソフトウェア
• 世界の性感染症（STD）検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定
• 分子診断
• 世界の性感染症（STD）検査市場：サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液サンプル
• 尿サンプル
• 綿棒
• 精液サンプル
• その他のサンプルタイプ
• 世界の性感染症（STD）検査市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クラミジア
• 淋病
• 梅毒
• HIVまたはエイズ
• 単純ヘルペスウイルス（HSV）
• 世界の性感染症（STD）検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 個人
• ヘルスケア提供者
• 健康保険会社
• 政府の保健機関
• NGOと地域保健団体
• 世界の性感染症（STD）検査市場、機器とサービス、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断機器
• テストサービス
• 世界の性感染症（STD）検査市場、消耗品、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬とキット
• 検体採取装置
• スライド、チューブ、その他の実験用品
• 世界の性感染症（STD）検査市場、ソフトウェア、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査情報管理システム（LIMS）
• 電子健康記録（EHR）統合ツール
• データ分析およびレポートツール
• 患者管理ソフトウェア

第7章 地域別・国別分析

• 世界の性感染症（STD）検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の性感染症（STD）検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 性感染症（STD）検査市場：競合情勢
• 性感染症（STD）検査市場：企業プロファイル
  • F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson And Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Hologic Inc.
• QuidelOrtho Corp.
• Bio-Rad Laboratories Inc.
• Cepheid
• OraSure Technologies Inc.
• Meridian Bioscience Inc.
• Sekisui Diagnostics Ltd.
• Trinity Biotech Plc
• Chembio Diagnostics Inc.
• Operon SA
• Jal Medical Pte. Ltd.
• Anatolia Geneworks
• CLIAwaived Inc.
• Avecon Healthcare Pvt. Ltd.
• AEHEALTH LIMITED

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 性感染症（STD）検査市場2029：新たな機会を提供する国
• 性感染症（STD）検査市場2029：新たな機会を提供するセグメント
• 性感染症（STD）検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sexually transmitted disease (STD) testing refers to the medical procedure used to detect infections primarily transmitted through sexual contact. It is essential for early diagnosis, which helps prevent complications and controls the spread of infections through timely treatment and counseling. Regular screening is often advised for sexually active individuals since many infections may not present immediate symptoms but can still be contagious.

The main components of sexually transmitted disease (STD) testing include instruments and services, consumables, and software. Instruments and services comprise the diagnostic devices and support activities utilized in clinical environments for conducting medical tests. These employ both immunoassay and molecular diagnostic technologies and can analyze blood, urine, swabs, semen, and other sample types. This testing is applied for various diseases such as chlamydia, gonorrhea, syphilis, HIV/AIDS, and herpes simplex virus (HSV), serving a range of end users including individuals, healthcare providers, health insurers, government health agencies, NGOs, and community health organizations.

The sexually transmitted diseases (STD) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted diseases (STD) testing market statistics, including sexually transmitted diseases (STD) testing industry global market size, regional shares, competitors with a sexually transmitted diseases (STD) testing market share, detailed sexually transmitted diseases (STD) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted diseases (STD) testing industry. This sexually transmitted diseases (STD) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted diseases (STD) testing market size has grown strongly in recent years. It will grow from $8.08 billion in 2024 to $8.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. Growth during the past years has been driven by increasing urbanization and population density, a growing aging population maintaining active sexual lifestyles, government efforts to promote STD screening, the integration of STD testing into routine health examinations, and greater funding for public health initiatives.

The sexually transmitted diseases (STD) testing market size is expected to see strong growth in the next few years. It will grow to $12.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. This anticipated expansion can be credited to the rising global incidence of STDs, enhanced awareness of sexual health issues, the high rate of infections without symptoms, the increasing number of sexually active adolescents and young adults, and a surge in risky sexual behaviors. Key trends forecasted include the rise of rapid and point-of-care testing, the emergence of home-based STD testing kits, progress in molecular diagnostic methods, greater automation and AI integration in diagnostic labs, and improved accuracy and reliability of new testing kits.

The increasing prevalence of HIV is expected to drive the growth of the sexually transmitted diseases (STD) testing market in the upcoming years. HIV attacks and destroys vital white blood cells, weakening the immune system and making the body more susceptible to infections and diseases. The rise in HIV cases is linked to a decline in awareness and prevention efforts, leading to more individuals engaging in risky behaviors such as unprotected sex and fewer people, especially youth, getting tested. This increase in HIV cases has raised public and healthcare awareness, encouraging more people to seek comprehensive testing to detect infections early and prevent further spread. For example, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2024, approximately 1.3 million people were newly infected with HIV in 2023, nearly three times higher than the 2025 target of fewer than 370,000 cases. Therefore, the growing prevalence of HIV is expected to enhance the demand for STD testing.

Key players in the sexually transmitted diseases (STD) testing market are focusing on the development of advanced solutions, such as syphilis testing kits, to improve accessibility and accuracy. These kits detect the Treponema pallidum bacteria, which causes syphilis, using blood or other bodily fluids, enabling timely diagnosis and treatment. For instance, in August 2023, iHealth Labs Inc., a US medical device company, launched the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples at home for HIV (I, II, P24 antigen) and syphilis testing. Users can send their samples to the lab with a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers high accuracy, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are tested in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with stringent federal and state quality standards through regular inspections.

In December 2023, imaware, a US-based company providing at-home health testing kits, acquired binx health's at-home consumer testing division. This acquisition will help imaware strengthen its position in the growing home-health testing market and expand its enterprise client base. Meanwhile, binx health will continue to develop and grow its point-of-care molecular diagnostics division, which was not part of the acquisition. Binx health is a US-based provider of sexually transmitted disease (STD) testing solutions.

Major players in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., and AEHEALTH LIMITED.

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted diseases (STD) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted diseases (STD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted diseases (STD) testing market consists of revenues earned by entities by providing services such as confidential testing, walk-in clinic testing, online test ordering, telehealth consultations, and partner notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted diseases (STD) testing market also includes sales of at-home test kits, multi-infection panel kits, blood collection devices, biohazard specimen bags, and portable sample storage containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Diseases (STD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted diseases (std) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted diseases (std) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sexually transmitted diseases (std) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments And Services; Consumables; Software
• 2) By Technology: Immunoassay; Molecular Diagnostics
• 3) By Sample Type: Blood Samples; Urine Samples; Swabs; Semen Samples; Other Sample Types
• 4) By Disease Type: Chlamydia; Gonorrhea; Syphilis; HIV Or AIDS; Herpes Simplex Virus (HSV)
• 5) By End User: Individuals; Healthcare Providers; Health Insurance Providers; Govement Health Agencies; NGOs And Community Health Organizations
• Subsegments:
• 1) By Instruments And Services: Diagnostic Instruments; Testing Services
• 2) By Consumables: Reagents And Kits; Specimen Collection Devices; Slides, Tubes, And Other Lab Supplies
• 3) By Software: Laboratory Information Management Systems (LIMS); Electronic Health Records (EHR) Integration Tools; Data Analysis And Reporting Tools; Patient Management Software
• Companies Mentioned: F Hoffmann La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Siemens Healthineers AG; Becton Dickinson And Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Diseases (STD) Testing Market Characteristics

3. Sexually Transmitted Diseases (STD) Testing Market Trends And Strategies

4. Sexually Transmitted Diseases (STD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sexually Transmitted Diseases (STD) Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sexually Transmitted Diseases (STD) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sexually Transmitted Diseases (STD) Testing Market Growth Rate Analysis
• 5.4. Global Sexually Transmitted Diseases (STD) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sexually Transmitted Diseases (STD) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sexually Transmitted Diseases (STD) Testing Total Addressable Market (TAM)

6. Sexually Transmitted Diseases (STD) Testing Market Segmentation

• 6.1. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments And Services
• Consumables
• Software
• 6.2. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay
• Molecular Diagnostics
• 6.3. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Samples
• Urine Samples
• Swabs
• Semen Samples
• Other Sample Types
• 6.4. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chlamydia
• Gonorrhea
• Syphilis
• HIV Or AIDS
• Herpes Simplex Virus (HSV)
• 6.5. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Individuals
• Healthcare Providers
• Health Insurance Providers
• Govement Health Agencies
• NGOs And Community Health Organizations
• 6.6. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Instruments
• Testing Services
• 6.7. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Specimen Collection Devices
• Slides, Tubes, and Other Lab Supplies
• 6.8. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Information Management Systems (LIMS)
• Electronic Health Records (EHR) Integration Tools
• Data Analysis And Reporting Tools
• Patient Management Software

7. Sexually Transmitted Diseases (STD) Testing Market Regional And Country Analysis

• 7.1. Global Sexually Transmitted Diseases (STD) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sexually Transmitted Diseases (STD) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market

• 8.1. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Diseases (STD) Testing Market

• 9.1. China Sexually Transmitted Diseases (STD) Testing Market Overview
• 9.2. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Diseases (STD) Testing Market

• 10.1. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Diseases (STD) Testing Market

• 11.1. Japan Sexually Transmitted Diseases (STD) Testing Market Overview
• 11.2. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Diseases (STD) Testing Market

• 12.1. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Diseases (STD) Testing Market

• 13.1. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Diseases (STD) Testing Market

• 14.1. South Korea Sexually Transmitted Diseases (STD) Testing Market Overview
• 14.2. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Diseases (STD) Testing Market

• 15.1. Western Europe Sexually Transmitted Diseases (STD) Testing Market Overview
• 15.2. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Diseases (STD) Testing Market

• 16.1. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Diseases (STD) Testing Market

• 17.1. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Diseases (STD) Testing Market

• 18.1. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Diseases (STD) Testing Market

• 19.1. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Diseases (STD) Testing Market

• 20.1. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market

• 21.1. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market Overview
• 21.2. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Diseases (STD) Testing Market

• 22.1. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Diseases (STD) Testing Market

• 23.1. North America Sexually Transmitted Diseases (STD) Testing Market Overview
• 23.2. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Diseases (STD) Testing Market

• 24.1. USA Sexually Transmitted Diseases (STD) Testing Market Overview
• 24.2. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Diseases (STD) Testing Market

• 25.1. Canada Sexually Transmitted Diseases (STD) Testing Market Overview
• 25.2. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Diseases (STD) Testing Market

• 26.1. South America Sexually Transmitted Diseases (STD) Testing Market Overview
• 26.2. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Diseases (STD) Testing Market

• 27.1. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Diseases (STD) Testing Market

• 28.1. Middle East Sexually Transmitted Diseases (STD) Testing Market Overview
• 28.2. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Diseases (STD) Testing Market

• 29.1. Africa Sexually Transmitted Diseases (STD) Testing Market Overview
• 29.2. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape And Company Profiles

• 30.1. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape
• 30.2. Sexually Transmitted Diseases (STD) Testing Market Company Profiles
  • 30.2.1. F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson And Co. Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Diseases (STD) Testing Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. QuidelOrtho Corp.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Cepheid
• 31.5. OraSure Technologies Inc.
• 31.6. Meridian Bioscience Inc.
• 31.7. Sekisui Diagnostics Ltd.
• 31.8. Trinity Biotech Plc
• 31.9. Chembio Diagnostics Inc.
• 31.10. Operon SA
• 31.11. Jal Medical Pte. Ltd.
• 31.12. Anatolia Geneworks
• 31.13. CLIAwaived Inc.
• 31.14. Avecon Healthcare Pvt. Ltd.
• 31.15. AEHEALTH LIMITED

32. Global Sexually Transmitted Diseases (STD) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Diseases (STD) Testing Market

34. Recent Developments In The Sexually Transmitted Diseases (STD) Testing Market

35. Sexually Transmitted Diseases (STD) Testing Market High Potential Countries, Segments and Strategies

• 35.1 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer